Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivoYuchen Zhang, Ning Liao|Cell Communication and Signaling|2022Cited by 33
Genomic alteration profile and <scp>PD‐L1</scp> expression among different breast cancer subtypes in Chinese population and their correlationsKai Li, Ning Liao|Cancer Medicine|2022Cited by 4